5 research outputs found
Over-expression of ÎČ-catenin is associated with high grade of prostatic cancer in Libyan patients
Objectives: At present, sufficient prognostic markers for prostate cancer (PCa) progression are still lacking, in spite of thorough investigation. The aim of this study was to evaluate abnormalities of ÎČ-catenin protein expression, subcellular localization and determine its relation to different clinicopathological features anddisease free survival in prostate cancer patients.Patients and methods: Forty prostate cancer specimens, obtained from patients with different stages of prostate cancer (83% stage IV) who underwent a radical prostatectomy or TURP flanked by 2006 and 2011, ÎČ-catenin was determined by immuno-histochemistry (IHC). The membranous expression was semi- quantitatively evaluated in four scores (0, 1+, 2+, 3+). Clinical records of these patients were studied for follow up data.Results: ÎČ-Catenin immune staining results show over-expression of ÎČ-catenin in PCa Libyan patients. There was no statistically significant difference in ÎČ-catenin immune expression as regards histopathological type, perineural invasion, tumor stage, biological recurrence. However, ÎČ-catenin over-expression showed significant correlation with old age (p < 0.014).Conclusions: We concluded that changes in expression and cell distribution of ÎČ-catenin correlated with the progression degree of prostate adenocarcinoma, signifying a role of this molecule as a marker of progression and prognosis. Further investigations, on a larger and more heterogeneous population, should be carried out to validate and extend our results.Keywords: Prostate cancer; ÎČ-Catenin expression; Immuno-histochemistry; Gleason score; Prognosi
Identifying chemokines as therapeutic targets in renal disease: Lessons from antagonist studies and knockout mice
Chemokines, in concert with cytokines and adhesion molecules, play multiple roles in local and systemic immune responses. In the kidney, the temporal and spatial expression of chemokines correlates with local renal damage and accumulation of chemokine receptor-bearing leukocytes. Chemokines play important roles in leukocyte trafficking and blocking chemokines can effectively reduce renal leukocyte recruitment and subsequent renal damage. However, recent data indicate that blocking chemokine or chemokine receptor activity in renal disease may also exacerbate renal inflammation under certain conditions. An increasing amount of data indicates additional roles of chemokines in the regulation of innate and adaptive immune responses, which may adversively affect the outcome of interventional studies. This review summarizes available in vivo studies on the blockade of chemokines and chemokine receptors in kidney diseases, with a special focus on the therapeutic potential of anti-chemokine strategies, including potential side effects, in renal disease. Copyright (C) 2004 S. Karger AG, Basel
Angiogenesis in urinary bladder carcinoma as defined by microvessel density (MVD) after immunohistochemical staining for Factor VIII and CD31
Background: Among the patients with bladder cancer, a group is still at risk of disease recurrence, progression, and death from their cancer after curative treatment. Angiogenesis is a crucial pathogenic mechanism for this type of urothelial carcinoma and is a potential therapeutic target. Objectives: To quantify tumor angiogenesis in bladder cancer and determine whether it correlates with tumor stage and grade. Patients and methods: A series of 42 archival samples from carcinomas of the urinary bladder were graded, staged, and analyzed for microvessel density (MVD) by a double immunohistochemical technique using Factor VIII (FVIII) and CD31 antibodies. The correlation between MVD and histopathological grade and tumor stage was evaluated. Results: FVIII and CD31 immunoreactivity was observed in 100% of cases and more intensely with CD31. Significantly higher MVD was determined in invasive tumors than in superficial tumors (p<0.05). MVD increased with tumor grade and stage (p<0.05); MVD was not affected by age or sex of the patients. Conclusion: These data demonstrate that MVD in bladder carcinoma correlates with the tumor grade and stage. Quantification of tumor angiogenesis may allow selection of the type of treatment for bladder cancer patients
Primary bone tumour in eastern Libya - a 10 year study
In this study the frequency of primary bone tumours in the eastern part of Libya during a period of 1O years (1981 to 1990) is analysed. During this period 165 histologically proved primary bone tumours were seen. Out of these 165 tumours 40 were malignant and 125 were benign. Males were more frequently affected by the primary bone tumours. The second decade was the most common age of incidence for both benign and malignant tumours. The femur was the most common site. Comparison with similar studies from selected parts of the world indicated that the frequency of primary malignant bone tumours in Eastern Libya appears to be low